KRAS and colorectal carcinoma: At the same time, Fernández et al. (2021) tested five plant flavonoids for their potential as antitumor drugs against the same human CRC cell lines plus T84 (epithelial morphology, adenocarcinoma, metastasis in lung, KRAS mutant, BRAF wild type).